share_log

424B5: Prospectus

SEC announcement ·  Jul 25 05:10
Summary by Futu AI
60 Degrees Pharmaceuticals, trading under the symbol SXTP on The Nasdaq Capital Market, has filed a prospectus supplement on July 24, 2024, to increase the maximum aggregate gross sales price of shares offered under its Sales Agreement with WallachBeth Capital LLC to $1,890,705. This move, referred to as the ATM Offering Size Increase, amends previous registrations of common stock worth $1,253,603 and $1,774,640. As of the filing date, 60 Degrees Pharmaceuticals has sold 4,964,249 shares for a gross sales price of $0.2811 per share. The company's outstanding common stock held by non-affiliates is valued at approximately $5,672,117, based on a share price of $0.351 as of June 7, 2024. The company adheres to the SEC's General Instruction I.B.6 of Form S-3, which limits the sale of securities in a public primary offering to no more than one-third of the public float in a 12-month period, provided the public float is below $75 million. The prospectus supplement also highlights significant investment risks, as detailed in the Risk Factors sections of the accompanying documents and filings with the SEC.
60 Degrees Pharmaceuticals, trading under the symbol SXTP on The Nasdaq Capital Market, has filed a prospectus supplement on July 24, 2024, to increase the maximum aggregate gross sales price of shares offered under its Sales Agreement with WallachBeth Capital LLC to $1,890,705. This move, referred to as the ATM Offering Size Increase, amends previous registrations of common stock worth $1,253,603 and $1,774,640. As of the filing date, 60 Degrees Pharmaceuticals has sold 4,964,249 shares for a gross sales price of $0.2811 per share. The company's outstanding common stock held by non-affiliates is valued at approximately $5,672,117, based on a share price of $0.351 as of June 7, 2024. The company adheres to the SEC's General Instruction I.B.6 of Form S-3, which limits the sale of securities in a public primary offering to no more than one-third of the public float in a 12-month period, provided the public float is below $75 million. The prospectus supplement also highlights significant investment risks, as detailed in the Risk Factors sections of the accompanying documents and filings with the SEC.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.